glp-1 receptor agonists in pediatric and adolescent obesity prescribing among teens with Frontiers | Beyond lifestyle modification:

In vitro , Ma and colleagues [90] also showed liraglutide to reduce H 2 O 2 -related damage in RGCs through inhibition of mitophagy induction, primarily by reducing ROS and maintaining mitochondrial membrane potential

In this narrative literature review, we explore the pharmacological properties of tirzepatide and critically summarize and comment on the results of the clinical studies conducted thus far, as well as discuss the potential implications for the treatment of obesity, T2DM, and associated cardiometabolic complications

GLP-1 receptor agonists have been shown in multiple studies to exert anti-inflammatory effects, including inhibition of monocyte chemotaxis, suppression of macrophage inflammatory responses, and AMPK-mediated downregulation of the NF-B signaling pathway, thereby reducing systemic inflammation (36)

These broader changes could have a wide-ranging impact on companies across numerous sectors including healthcare, pharmaceuticals, insurers, medical device companies, the food and beverage industry, retailers, fitness businesses, airlines and many more